Literature DB >> 29371385

Both moderate and severe exacerbations accelerate physical activity decline in COPD patients.

Heleen Demeyer1,2,3,4,5,6, Marcos Costilla-Frias3,7,6, Zafeiris Louvaris1,8, Elena Gimeno-Santos2,3,4,9, Maggie Tabberer10, Roberto A Rabinovich11, Corina de Jong12,13, Michael I Polkey14, Nicholas S Hopkinson14, Niklas Karlsson15, Ignasi Serra2,3,4, Ioannis Vogiatzis8,16, Thierry Troosters1,5, Judith Garcia-Aymerich17,3,4.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29371385     DOI： 10.1183/13993003.02110-2017

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  8 in total

1.  Differences in Sedentary Time, Light Physical Activity, and Steps Associated with Better COPD Quality of Life.

Authors:  C Noelle Driver; Paul J Novotny; Roberto P Benzo
Journal:  Chronic Obstr Pulm Dis       Date:  2022-01-27

2.  No impact of exacerbation frequency and severity on the physical activity decline in COPD: a long-term observation.

Authors:  Noriane A Sievi; Malcolm Kohler; Robert Thurnheer; Joerg D Leuppi; Sarosh Irani; Martin Frey; Martin Brutsche; Thomas Brack; Christian F Clarenbach
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-02-15

3.  PRIMUS - Prompt Initiation of Maintenance Therapy in the US: A Real-World Analysis of Clinical and Economic Outcomes Among Patients Initiating Triple Therapy Following a COPD Exacerbation.

Authors:  Joseph Tkacz; Kristin A Evans; Daniel R Touchette; Edward Portillo; Charlie Strange; Anthony Staresinic; Norbert Feigler; Sushma Patel; Michael Pollack
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-02-10

4.  Effect of targeted nutrient supplementation on physical activity and health-related quality of life in COPD: study protocol for the randomised controlled NUTRECOVER trial.

Authors:  Rosanne Jhcg Beijers; Lieke E J van Iersel; Lisanne T Schuurman; Robert J J Hageman; Sami O Simons; Ardy van Helvoort; Harry R Gosker; Annemie Mwj Schols
Journal:  BMJ Open       Date:  2022-03-16       Impact factor: 2.692

5.  Can COPD Exacerbations Be Picked Up Early via a Weekly Medication Question Through a Smartphone Application?

Authors:  Astrid Blondeel; Heleen Demeyer; Sofie Breuls; Marieke Wuyts; Lies Glorie; Nikolaas De Maeyer; Wim Janssens; Thierry Troosters
Journal:  Front Rehabil Sci       Date:  2022-01-26

6.  Connecting real-world digital mobility assessment to clinical outcomes for regulatory and clinical endorsement-the Mobilise-D study protocol.

Authors:  A Stefanie Mikolaizak; Lynn Rochester; Walter Maetzler; Basil Sharrack; Heleen Demeyer; Claudia Mazzà; Brian Caulfield; Judith Garcia-Aymerich; Beatrix Vereijken; Valdo Arnera; Ram Miller; Paolo Piraino; Nadir Ammour; Mark Forrest Gordon; Thierry Troosters; Alison J Yarnall; Lisa Alcock; Heiko Gaßner; Jürgen Winkler; Jochen Klucken; Christian Schlenstedt; Henrik Watz; Anne-Marie Kirsten; Ioannis Vogiatzis; Nikolaos Chynkiamis; Emily Hume; Dimitrios Megaritis; Alice Nieuwboer; Pieter Ginis; Ellen Buckley; Gavin Brittain; Giancarlo Comi; Letizia Leocani; Jorunn L Helbostad; Lars Gunnar Johnsen; Kristin Taraldsen; Hubert Blain; Valérie Driss; Anja Frei; Milo A Puhan; Ashley Polhemus; Magda Bosch de Basea; Elena Gimeno; Nicholas S Hopkinson; Sara C Buttery; Jeffrey M Hausdorff; Anat Mirelman; Jordi Evers; Isabel Neatrour; David Singleton; Lars Schwickert; Clemens Becker; Carl-Philipp Jansen
Journal:  PLoS One       Date:  2022-10-06       Impact factor: 3.752

7.  Determinants and outcomes of change in physical activity in COPD.

Authors:  Ana Kantorowski; Emily S Wan; Diana Homsy; Reema Kadri; Caroline R Richardson; Marilyn L Moy
Journal:  ERJ Open Res       Date:  2018-08-03

8.  Exacerbations and Changes in Physical Activity and Sedentary Behaviour in Patients with Bronchiectasis after 1 Year.

Authors:  Victoria Alcaraz-Serrano; Ane Arbillaga-Etxarri; Patricia Oscanoa; Laia Fernández-Barat; Leticia Bueno; Rosanel Amaro; Elena Gimeno-Santos; Antoni Torres
Journal:  J Clin Med       Date:  2021-03-12       Impact factor: 4.241
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.